A NSW Government website

On

Neurology Research

Our Research Team

Associate Professor Rebekah Ahmed

Associate Professor, Brain and Mind Centre

Staff Specialist Neurologist, Royal Prince Alfred Hospital

Professor Craig Anderson

Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW

Neurologist, Royal Prince Alfred Hospital

Professor Michael Barnett
MBBS (Hons), FRACP, FRCP, PhD

Consultant Neurologist, Royal Prince Alfred Hospital

Senior Academic, University of Sydney

Director, RPA Muscular Sclerosis Clinic and Muscular Sclerosis Clinical Trials Unit, Brain and Mind Centre

Co-director, MS Research Australia Brain Bank

Professor G. Michael Halmagyi

Consultant Neurologist, Royal Prince Alfred Hospital

Professor of Neurology, University of Sydney

Professor Matthew Kiernan AM
MBBS (Hons) (USYD), PhD (UNSW), DSc (UNSW), FRACP, FAHMS, FAA
Consultant Neurologist, Royal Prince Alfred Hospital,
Scientia Professor of Neuroscience at UNSW
Associate Professor Armin (Mohamed) Nikpour
MBBS (Hons), FRACP, BSc (Math)
Director, Comprehensive Epilepsy Service, Royal Prince Alfred Hospital and University of Sydney
Associate Professor Miriam Welgampola
BSc Med (Hon), FRACP, PhD

Consultant Neurologist, Royal Prince Alfred Hospital

Associate Professor of Neurology, University of Sydney

Associate Professor John Worthington Director, Comprehensive Stroke Service, Royal Prince Alfred Hospital

Selected Grants

Amount awarded Grant and project details
$909,646 NHMRC, 2025-2028
As we speak: Unmasking speech changes earlier in the course of disease.
Investigators: Ballard K, Szalay T, Proctor M, Gully A, Foster S, Ahmed R.
$2,953,040 NHMRC, 2024-2029
Innovative strategies to reduce the global burden of stroke.
Investigators: Anderson CS.
$2,806,584 MRFF, 2024-2029
CureMOG: A randomised double-blind placebo-controlledmulticentre phase III clinical trial for the treatment of MOGAD.
RPA Investigator: Barnett M.
$1,999,835 MRFF, 2024-2029
Fludrocortisone in ICU patients with aneurysmal subarachnoid haemorrhage.
Investigators: Cohen J, Anderson CS, Belapart J, Burrell L, Delaney A, Jeffree R, Li Q, Talbot P, Udy A, Young M.
$1,535,099 NHMRC, 2024-2029
ACT-GLOBAL platform trial to resolve uncertainty over thrombolysis treatment in acute ischaemic stroke.
Investigators: Anderson CS, Chen X, Menon B, Hill M, Campbell B, Parsons MW, Demchuk A, Sandset EC, Saver J, Sylaja PN.
$3,743,490 NHRMC, 2024-2028
Atrial Myopathy and Embolic Stroke (AMES) trial.
RPA Investigator: Blair C
$2,000,000 MRFF, 2024-2028
A new tool to optimise the early and accurate diagnosis of frontotemporal dementia.
Investigators: Irish M, Ahmed R, Piguet P, Kumfor F.
$1,350,000 NHMRC, 2024-2028
Pregnancy and the multiple sclerosis brain.
RPA Investigator: Beadnall H.
$5,000,000 NHMRC, 2024-2026
Synergise, Integrate and Enhance Sleep Research to Transform Brain Ageing (SIESTA).
Investigators: Mater E, Michaelian J, Shahab R, Wehrman J, Naismith S, Sanders R.
$1,478,000 New South Wales Biosciences Fund, 2024-2026
Companion Study to the Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke (Co-STARS) Trial.
Investigator: Blair C.
$1,999,362 MRFF, 2023-2028
A phase III, multicentre, randomised, double-blinded, placebo-controlled clinical trial of SpironolacTOne and famciclovir in Progressive Multiple Sclerosis: the STOP-MS trial.
RPA Investigator: Barnett M.
$1,600,000 MRFF, 2023-2027
A new tool to optimise the early and accurate diagnosis of frontotemporal dementia.
Investigators: Irish M, Foxe D, Jeon Y, Velakoulis D, Robinson G, Whitton A, Kumfor F, Low L, Piguet O, Ahmed R.
$3,711,898 NHMRC, 2023-2026
INTErGenerational intervention to Reduce fraIlTY trial (INTEGRITY).
Investigators: Peters R, Rockwood K, Fitzgerald J, Delbaere K, Ward S, Anderson C, Kimonis E, Hubbard R, Kurrle S, Janda M.
$2,927,077 MRFF, 2023-2026
AIS-SHIELDS: Securing Health Intelligence Efforts & Linking Data Silos.
Investigators: Sullivan R, Barnett MH, Wang CT.
$3,000,000 NHMRC, 2022-2027
NHMRC Centre of Research Excellence in Enhanced Dementia Diagnosis (CREEDD). 
Investigators: Ayton S, Brodtman A, Bush A, Ayton D, Bammer R, Lim Y, Wooward M, Ahmed RM, Ahern S, Liew D.
$2,029,361 MRFF, 2022-2025
Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED-MT).
Investigators: Anderson C, Song L, Chen X, Parsons M, Wang X, Butcher K, Campbell B.
$1,774,988 MRFF, 2022-2025
Optimal Post rTPA-iv Monitoring in Ischaemic Stroke (OPTIMISTmain) clinical trial.
RPA Investigator: Anderson CS.
$999,632 MRFF, 2022-2025
Non-invasive imaging of atherosclerotic plaque: quantification of disease activity for improved identification of patients with residual cardiovascular risk.
Investigators: Blair C
$530,000 Fight MND Research Grant, 2022-2025
Multi-arm, Adaptive, Group sequential trial NETwork to evaluate drug efficacy in patients with MND (MAGNET).
Investigators: Kiernan MC.
$2,795,200 NHMRC, 2021-2026
Clinical trial to determine the effects of statins on cognition: STAREE-Mind
Investigators: Ryan J, Zoungas S, Anderson C, Law M, Chong T, Harding I, Heritier S, Naismith S, O’Sullivan M, Liew D

Our Publications

2024

Gressie K, Kumfor F, Teng H, Foxe D, Devenney E, Ahmed RM, Piguet O. Error profiles of facial emotion recognition in frontotemporal dementia and Alzheimer's disease. Int Psychogeriatr. 2024 Jun;36(6):455-464. doi: 10.1017/S1041610223000297. Epub 2023 Apr 11. 
Foong YC, Merlo D, Gresle M, Zhu C, Buzzard K, Lechner-Scott J, Barnett M, Taylor B, Kalincik T, Kilpatrick T, Darby D, Dobay P, van Beek J, Hyde R, Butzkueven H, van der Walt A. The Patient-Determined Disease Steps scale is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis. Eur J Neurol. 2024 Jan;31(1):e16046. doi: 10.1111/ene.16046. Epub 2023 Aug 24. 
Li Y, Saul A, Taylor B, Ponsonby AL, Simpson-Yap S, Blizzard L, Broadley S, Lechner-Scott J; Ausimmune/AusLong Investigators Group; Karabudak R, Patti F, Eichau S, Onofrj M, Ozakbas S, Horakova D, Kubala Havrdova E, Grand'Maison F, Alroughani R, Gerlach O, Amato MP, Altintas A, Girard M, Duquette P, Blanco Y, Ramo-Tello C, Laureys G, Kalincik T, Khoury SJ, Shaygannejad V, Etemadifar M, Singhal B, Mrabet S, Foschi M, Habek M, John N, Hughes S, McCombe P, Ampapa R, van der Walt A, Butzkueven H, de Gans K, McGuigan C, Oreja-Guevara C, Sa MJ, Petersen T, Al-Harbi T, Sempere AP, Van Wijmeersch B, Grigoriadis N, Prevost J, Gray O, Castillo-Triviño T, Macdonell R, Lugaresi A, Sajedi SA; MSBase; van der Mei I. Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies. J Neurol. 2024 Jan;271(1):472-485. doi: 10.1007/s00415-023-11980-z. Epub 2023 Sep 28. 
Gunawardana CW, Matar E, Lewis SJG. The clinical phenotype of psychiatric-onset prodromal dementia with Lewy bodies: a scoping review. J Neurol. 2024 Jan;271(1):606-617. doi: 10.1007/s00415-023-12000-w. Epub 2023 Oct 4. 
Hannigan IP, Rosengren SM, Bharathy GK, Prasad M, Welgampola MS, Watson SRD. Subjective and objective responses to caloric stimulation help separate vestibular migraine from other vestibular disorders. J Neurol. 2024 Feb;271(2):887-898. doi: 10.1007/s00415-023-12027-z. Epub 2023 Oct 17. 
Selmaj K, Cree BAC, Barnett M, Thompson A, Hartung HP. Multiple sclerosis: time for early treatment with high-efficacy drugs. J Neurol. 2024 Jan;271(1):105-115. doi: 10.1007/s00415-023-11969-8. Epub 2023 Oct 18. 
Kwok BYC, Young AS, Kong JHK, Birman CS, Flanagan S, Greenberg SL, Gibson WP, Argaet EC, Fratturo L, Pogson JM, Taylor RL, Rosengren SM, Halmagyi GM, Welgampola MS. Post Cochlear Implantation Vertigo: Ictal Nystagmus and Audiovestibular Test Characteristics. Otol Neurotol. 2024 Jan 1;45(1):65-74. doi: 10.1097/MAO.0000000000004037. Epub 2023 Oct 14. 
Horne K, Ahmed RM, Piguet O, Irish M. Establishing the link between motivational disturbances and behavioural rigidity in frontotemporal dementia. Eur J Neurol. 2024 Feb;31(2):e16132. doi: 10.1111/ene.16132. Epub 2023 Nov 7. 
You S, Zheng D, Yoshimura S, Ouyang M, Han Q, Wang X, Cao Y, Delcourt C, Song L, Arima H, Chen X, Liu CF, Lindley RI, Robinson T, Anderson CS, Chalmers J; INTERACT Investigators. Optimum Baseline Clinical Severity Scale Cut Points for Prognosticating Intracerebral Hemorrhage: INTERACT Studies. Stroke. 2024 Jan;55(1):139-145. doi: 10.1161/STROKEAHA.123.044538. Epub 2023 Nov 29. 
Butzkueven H, Ponsonby AL, Stein MS, Lucas RM, Mason D, Broadley S, Kilpatrick T, Lechner-Scott J, Barnett M, Carroll W, Mitchell P, Hardy TA, Macdonell R, McCombe P, Lee A, Kalincik T, van der Walt A, Lynch C, Abernethy D, Willoughby E, Barkhof F, MacManus D, Clarke M, Andrew J, Morahan J, Zhu C, Dear K, Taylor BV; PREVANZ Investigators. Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome. Brain. 2024 Apr 4;147(4):1206-1215. doi: 10.1093/brain/awad409.
Li Q, Yakhkind A, Alexandrov AW, Alexandrov AV, Anderson CS, Dowlatshahi D, Frontera JA, Hemphill JC, Ganti L, Kellner C, May C, Morotti A, Parry-Jones A, Sheth KN, Steiner T, Ziai W, Goldstein JN, Mayer SA. Code ICH: A Call to Action. Stroke. 2024 Feb;55(2):494-505. doi: 10.1161/STROKEAHA.123.043033. Epub 2023 Dec 15.
Anderson CS. Stroke advances in 2023: a new horizon for the management of intracerebral haemorrhage. Lancet Neurol. 2024 Jan;23(1):12-13. doi: 10.1016/S1474-4422(23)00451-9.
Jiang C, Zhao M, Li M, Wang Z, Bai Y, Guo H, Li S, Lai Y, Wang Y, Gao M, He L, Guo X, Li S, Liu N, Jiang C, Tang R, Long D, Sang C, Du X, Dong J, Anderson CS, Ma C. Orthostatic blood pressure changes do not influence cognitive outcomes following intensive blood pressure control. J Intern Med. 2024 Apr;295(4):557-568. doi: 10.1111/joim.13758. Epub 2023 Dec 18.
Hannigan IP, Rosengren SM, Di Tanna GL, Watson SRD, Welgampola MS. Effects of nonprescription therapies on vestibular migraine: a questionnaire-based observational study. Intern Med J. 2024 Jun;54(6):916-924. doi: 10.1111/imj.16314. Epub 2024 Jan 10.
Shajahan S, Peters R, Carcel C, Woodward M, Harris K, Anderson CS. Hypertension and Mild Cognitive Impairment: State-of-the-Art Review. Am J Hypertens. 2024 May 15;37(6):385-393. doi: 10.1093/ajh/hpae007.
Akdal G, Özçelik P, Balcı B, Halmágyi GM, Ünal B. One simple question detects motion sickness susceptibility in migraine patients. Braz J Otorhinolaryngol. 2024 Mar-Apr;90(2):101382. doi: 10.1016/j.bjorl.2023.101382. Epub 2023 Dec 19.
Hardy TA, Aouad P, Barnett MH, Blum S, Broadley S, Carroll WM, Crimmins D, Griffiths D, Hodgkinson S, Lechner-Scott J, Lee A, Malhotra R, McCombe P, Parratt J, Plummer C, Van der Walt A, Martel K, Walker RA. Onboarding of siponimod in secondary progressive multiple sclerosis patients in Australia: Novel, real-world evidence from the MSGo digital support programme. Mult Scler J Exp Transl Clin. 2024 Jan 12;10(1):20552173231226106. doi: 10.1177/20552173231226106.
Chen C, Ren X, Zhao Y, Ouyang M, Li Mbiostat Q, Wang X, Li Y, You S, Wang Y, Robinson TG, Lindley R, Arima H, Chalmers J, Li G, Chen X, Anderson CS, Song L; ENCHANTED Investigators. Intensive Blood Pressure Lowering and Renal Function in Ischemic Stroke Patients: Secondary Analysis of the ENCHANTED Trial. Cerebrovasc Dis. 2024;53(6):703-710. doi: 10.1159/000536275. Epub 2024 Jan 17.
Lan F, Roquet D, Dalton MA, El-Omar H, Ahmed RM, Piguet O, Irish M. Exploring graded profiles of hippocampal atrophy along the anterior-posterior axis in semantic dementia and Alzheimer's disease. Neurobiol Aging. 2024 Mar;135:70-78. doi: 10.1016/j.neurobiolaging.2024.01.004. Epub 2024 Jan 12. 
Matar E, Marshall NS, Yee BJ. Efficacy of intravenous iron for restless legs syndrome-moving beyond monotherapy and into the "real world". Sleep. 2024 Jul 11;47(7):zsae022. doi: 10.1093/sleep/zsae022. 
Máté S, Soutter M, Liaros J, Hackett D, Barnett M, Singh MF, Fornusek C. The effects of hybrid functional electrical stimulation interval training on aerobic fitness and fatigue in people with advanced multiple sclerosis: An exploratory pilot training study. Mult Scler Relat Disord. 2024 Mar;83:105458. doi: 10.1016/j.msard.2024.105458. Epub 2024 Jan 23. 
Liyanage G, Trewin BP, Lopez JA, Andersen J, Tea F, Merheb V, Nguyen K, Lee FXZ, Fabis-Pedrini MJ, Zou A, Buckland A, Fok A, Barnett MH, Reddel SW, Marignier R, El Hajj A, Monif M, van der Walt A, Lechner-Scott J, Kermode AG, Kalincik T, Broadley SA, Dale RC, Ramanathan S, Brilot F; on behalf the Australasian MOGAD Study Group. The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease. J Neurol Neurosurg Psychiatry. 2024 May 14;95(6):544-553. doi: 10.1136/jnnp-2023-332851. 
Klistorner S, Barnett MH, Wang C, Parratt J, Yiannikas C, Klistorner A. Longitudinal enlargement of choroid plexus is associated with chronic lesion expansion and neurodegeneration in RRMS patients. Mult Scler. 2024 Apr;30(4-5):496-504. doi: 10.1177/13524585241228423. Epub 2024 Feb 6.
Sarraj A, Hassan AE, Abraham MG, Ortega-Gutierrez S, Kasner SE, Hussain MS, Chen M, Churilov L, Johns H, Sitton CW, Yogendrakumar V, Ng FC, Pujara DK, Blackburn S, Sundararajan S, Hu YC, Herial NA, Arenillas JF, Tsai JP, Budzik RF, Hicks WJ, Kozak O, Yan B, Cordato DJ, Manning NW, Parsons MW, Cheung A, Hanel RA, Aghaebrahim AN, Wu TY, Portela PC, Gandhi CD, Al-Mufti F, Pérez de la Ossa N, Schaafsma JD, Blasco J, Sangha N, Warach S, Kleinig TJ, Shaker F, Al Shaibi F, Toth G, Abdulrazzak MA, Sharma G, Ray A, Sunshine J, Opaskar A, Duncan KR, Xiong W, Samaniego EA, Maali L, Lechtenberg CG, Renú A, Vora N, Nguyen T, Fifi JT, Tjoumakaris SI, Jabbour P, Tsivgoulis G, Pereira VM, Lansberg MG, DeGeorgia M, Sila CA, Bambakidis N, Hill MD, Davis SM, Wechsler L, Grotta JC, Ribo M, Albers GW, Campbell BC; SELECT2 Investigators. Endovascular Thrombectomy for Large Ischemic Stroke Across Ischemic Injury and Penumbra Profiles. JAMA. 2024 Mar 5;331(9):750-763. doi: 10.1001/jama.2024.0572.
Wilson NA, Ahmed R, Piguet O, Irish M. Disrupted social perception in frontotemporal dementia and Alzheimer's disease - Associated cognitive processes and clinical implications. J Neurol Sci. 2024 Mar 15;458:122902. doi: 10.1016/j.jns.2024.122902. Epub 2024 Jan 24. 
Gandy M, Coleman H, Cutler H, Jones MP, Karin E, Kwan P, Nikpour A, Parratt K, Rayner G, Titov N, Todd L, Seil E, Winton-Brown T, Wu W, Dear BF. Comparative effectiveness of digital mental healthcare models for adults with epilepsy: A study protocol of a randomized controlled trial. Epilepsia Open. 2024 Apr;9(2):808-818. doi: 10.1002/epi4.12913. Epub 2024 Feb 12. 
Hoang P, Sturnieks DL, Butler A, Chaplin C, Hicks C, Lo J, Ratanapongleka M, Robinson S, Smith N, Turner J, Krishnan AV, Barnett M, Gandevia S, Lord SR, Menant JC. A custom-built step exergame training programme to prevent falls in people with multiple sclerosis: A multicentre randomised controlled trial. Mult Scler. 2024 Apr;30(4-5):571-584. doi: 10.1177/13524585241229360. Epub 2024 Feb 16. 
Sarraj A, Hill MD, Hussain MS, Abraham MG, Ortega-Gutierrez S, Chen M, Kasner SE, Churilov L, Pujara DK, Johns H, Blackburn S, Sundararajan S, Hu YC, Herial NA, Budzik RF, Hicks WJ, Arenillas JF, Tsai JP, Kozak O, Cordato DJ, Hanel RA, Wu TY, Portela PC, Gandhi CD, Al-Mufti F, Maali L, Gibson D, Pérez de la Ossa N, Schaafsma JD, Blasco J, Sangha N, Warach S, Kleinig TJ, Shaker F, Sitton CW, Nguyen T, Fifi JT, Jabbour P, Furlan A, Lansberg MG, Tsivgoulis G, Sila C, Bambakidis N, Davis S, Wechsler L, Albers GW, Grotta JC, Ribo M, Campbell BC, Hassan AE; SELECT2 Investigators; SELECT2 Collaborators; Vora N, Manning NW, Cheung A, Aghaebrahim AN, Paipa Merchán AJ, Sahlein D, Requena Ruiz M, Elijovich L, Arthur A, Al-Shaibi F, Samaniego EA, Duncan KR, Opaskar A, Ray A, Xiong W, Sunshine J, DeGeorgia M, Tjoumakaris S, Mendes Pereira V; SELECT2 Collaborators. Endovascular Thrombectomy Treatment Effect in Direct vs Transferred Patients With Large Ischemic Strokes: A Prespecified Analysis of the SELECT2 Trial. JAMA Neurol. 2024 Feb 8;81(4):327–35. doi: 10.1001/jamaneurol.2024.0206. Epub ahead of print. 
Wang X, Yang J, Moullaali TJ, Sandset EC, Woodhouse LJ, Law ZK, Arima H, Butcher KS, Delcourt C, Edwards L, Gupta S, Jiang W, Koch S, Potter J, Qureshi AI, Robinson TG, Al-Shahi Salman R, Saver JL, Sprigg N, Wardlaw J, Anderson CS, Sakamoto Y, Bath PM, Chalmers J; Blood Pressure in Acute Stroke (BASC) Investigators. Influence of Time to Achieve Target Systolic Blood Pressure on Outcome After Intracerebral Hemorrhage: The Blood Pressure in Acute Stroke Collaboration. Stroke. 2024 Apr;55(4):849-855. doi: 10.1161/STROKEAHA.123.044358. Epub 2024 Feb 27. 
Hurden A, Cotter I, Mowszowski L, Naismith S, Anderson CS. Perspectives of general practitioners and memory clinic patients on ageing and cognitive decline to inform the design of a decentralised antihypertensive dementia prevention trial. Cereb Circ Cogn Behav. 2024 Feb 15;6:100215. doi: 10.1016/j.cccb.2024.100215. 
Kyle K, Peters J, Jonker B, Barnett Y, Maamary J, Barnett M, Maller J, Wang C, Tisch S. Magnetic Resonance-Guided Focused Ultrasound for Treatment of Essential Tremor: Ventral Intermediate Nucleus Ablation Alone or Additional Posterior Subthalamic Area Lesioning? Mov Disord Clin Pract. 2024 May;11(5):504-514. doi: 10.1002/mdc3.14005. Epub 2024 Mar 12. 
Huang Z, Herbozo Contreras LF, Leung WH, Yu L, Truong ND, Nikpour A, Kavehei O. Efficient Edge-AI Models for Robust ECG Abnormality Detection on Resource-Constrained Hardware. J Cardiovasc Transl Res. 2024 Aug;17(4):879-892. doi: 10.1007/s12265-024-10504-y. Epub 2024 Mar 12. 
Yan YY, Chan LML, Wang MP, Kwok JYY, Anderson CS, Lee JJ. Technology-supported behavior change interventions for reducing sodium intake in adults: a systematic review and meta-analysis. NPJ Digit Med. 2024 Mar 18;7(1):72. doi: 10.1038/s41746-024-01067-y.
Wang C, Young AS, Raj C, Bradshaw AP, Nham B, Rosengren SM, Calic Z, Burke D, Halmagyi GM, Bharathy GK, Prasad M, Welgampola MS. Machine learning models help differentiate between causes of recurrent spontaneous vertigo. J Neurol. 2024 Jun;271(6):3426-3438. doi: 10.1007/s00415-023-11997-4. Epub 2024 Mar 23.
Riley N, Drudge C, Nelson M, Haltner A, Barnett M, Broadley S, Butzkueven H, McCombe P, Van der Walt A, Wong EOY, Merschhemke M, Adlard N, Walker R, Samjoo IA. Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons. Ther Adv Neurol Disord. 2024 Mar 23;17:17562864241239453. doi: 10.1177/17562864241239453.
Zhou Z, You S, Sakamoto Y, Xu Y, Ding S, Xu W, Li W, Yu J, Wang Y, Harris K, Delcourt C, Reeves MJ, Lindley RI, Parsons MW, Woodward M, Anderson C, Du X, Pu J, Wardlaw JM, Carcel C. Covert Cerebrovascular Changes in People With Heart Disease: A Systematic Review and Meta-Analysis. Neurology. 2024 Apr 23;102(8):e209204. doi: 10.1212/WNL.0000000000209204. Epub 2024 Mar 26. 
Máté S, Corr N, Hackett D, Barnett M, Singh MF, Fornusek C. Functional electrical stimulation combined with voluntary cycling accentuates VO2 response in people with severe multiple sclerosis: A pilot study. Mult Scler Relat Disord. 2024 May;85:105552. doi: 10.1016/j.msard.2024.105552. Epub 2024 Mar 20. 
Sharmin S, Roos I, Malpas CB, Iaffaldano P, Simone M, Filippi M, Kubala Havrdova E, Ozakbas S, Brescia Morra V, Alroughani R, Zaffaroni M, Patti F, Eichau S, Salemi G, Di Sapio A, Inglese M, Portaccio E, Trojano M, Amato MP, Kalincik T; Writing Group; Italian Multiple Sclerosis and Related Disorders Register and MSBase Study Group. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries. Lancet Child Adolesc Health. 2024 May;8(5):348-357. doi: 10.1016/S2352-4642(24)00047-6. Epub 2024 Mar 25. 
Bhatia KD, Pulcine E, Andrews I, Gupta S, Webster R, Troedson C, Dale RC, Lorentzos M, Parra-Farinas C, Worthington J, Tastula K, Ang T, Cheung A, Manning N, Muthusami P. Mechanical Thrombectomy for Pediatric Arterial Ischemic Stroke from Acute M2 Occlusion. AJNR Am J Neuroradiol. 2024 May 9;45(5):588-591. doi: 10.3174/ajnr.A8182.
Nguyen MTH, Sakamoto Y, Maeda T, Woodward M, Anderson CS, Catiwa J, Yazidjoglou A, Carcel C, Yang M, Wang X. Influence of Socioeconomic Status on Functional Outcomes After Stroke: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2024 May 7;13(9):e033078. doi: 10.1161/JAHA.123.033078. Epub 2024 Apr 19.
Sun J, Werdiger F, Blair C, Chen C, Yang Q, Bivard A, Lin L, Parsons M. Automatic segmentation of hemorrhagic transformation on follow-up non-contrast CT after acute ischemic stroke. Front Neuroinform. 2024 Apr 16;18:1382630. doi: 10.3389/fninf.2024.1382630.
Maeda T, Woodward M, Jun M, Sakamoto Y, Chen X, Matsushita K, Mancia G, Arima H, Anderson CS, Chalmers J, Harris K. Risk of recurrent stroke and dementia following acute stroke by changes in kidney function: results from the Perindopril Protection Against Recurrent Stroke Study. J Hypertens. 2024 Aug 1;42(8):1313-1321. doi: 10.1097/HJH.0000000000003711. Epub 2024 Mar 8.
Bai L, Wang D, Wang H, Barnett M, Cabezas M, Cai W, Calamante F, Kyle K, Liu D, Ly L, Nguyen A, Shieh CC, Sullivan R, Zhan G, Ouyang W, Wang C. Improving multiple sclerosis lesion segmentation across clinical sites: A federated learning approach with noise-resilient training. Artif Intell Med. 2024 Jun;152:102872. doi: 10.1016/j.artmed.2024.102872. Epub 2024 Apr 17.
Wyman-Chick KA, Chaudhury P, Bayram E, Abdelnour C, Matar E, Chiu SY, Ferreira D, Hamilton CA, Donaghy PC, Rodriguez-Porcel F, Toledo JB, Habich A, Barrett MJ, Patel B, Jaramillo-Jimenez A, Scott GD, Kane JPM. Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer's Disease: A Pragmatic Review for Clinicians. Neurol Ther. 2024 Jun;13(3):885-906. doi: 10.1007/s40120-024-00620-x. Epub 2024 May 8.
Devenney EM, Tse NY, O'Callaghan C, Kumfor F, Ahmed RM, Caga J, Hazelton JL, Carrick J, Halliday GM, Piguet O, Kiernan MC, Hodges JR. An attentional and working memory theory of hallucination vulnerability in frontotemporal dementia. Brain Commun. 2024 Apr 20;6(3):fcae123. doi: 10.1093/braincomms/fcae123.
Ouchida S, Parratt K, Nikpour A, Fairbrother G. Syncope vs. Seizure: Ictal Bradycardia and Ictal Asystole. Case Rep Neurol Med. 2024 May 6;2024:1299282. doi: 10.1155/2024/1299282.
Trewin BP, Dale RC, Qiu J, Chu M, Jeyakumar N, Dela Cruz F, Andersen J, Siriratnam P, Ma KKM, Hardy TA, van der Walt A, Lechner-Scott J, Butzkueven H, Broadley SA, Barnett MH, Reddel SW, Brilot F, Kalincik T, Ramanathan S; Australasian MOGAD Study Group. Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse. J Neurol Neurosurg Psychiatry. 2024 Oct 16;95(11):1054-1063. doi: 10.1136/jnnp-2024-333463.
Pack AM, Oskoui M, Williams Roberson S, Donley DK, French J, Gerard EE, Gloss D, Miller WR, Munger Clary HM, Osmundson SS, McFadden B, Parratt K, Pennell PB, Saade G, Smith DB, Sullivan K, Thomas SV, Tomson T, Dolan O'Brien M, Botchway-Doe K, Silsbee HM, Keezer MR. Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM. Neurology. 2024 Jun;102(11):e209279. doi: 10.1212/WNL.0000000000209279. Epub 2024 May 15. Erratum in: Neurology. 2025 Jan 14;104(1):e210145. doi: 10.1212/WNL.0000000000210145. 
Li G, Lin Y, Yang J, Anderson CS, Chen C, Liu F, Billot L, Li Q, Chen X, Liu X, Ren X, Zhang C, Xu P, Wu L, Wang F, Qiu D, Jiang M, Peng Y, Li C, Huang Y, Zhao X, Liang J, Wang Y, Wu X, Xu X, Chen G, Huang D, Zhang Y, Zuo L, Ma G, Yang Y, Hao J, Xu X, Xiong X, Tang Y, Guo Y, Yu J, Li S, He S, Mao F, Tan Q, Tan S, Yu N, Xu R, Sun M, Li B, Guo J, Liu L, Liu H, Ouyang M, Si L, Arima H, Bath PM, Ford GA, Robinson T, Sandset EC, Saver JL, Sprigg N, van der Worp HB, Song L; INTERACT4 investigators; INTERACT4 Investigators. Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke. N Engl J Med. 2024 May 30;390(20):1862-1872. doi: 10.1056/NEJMoa2314741. Epub 2024 May 16. 
Nguyen PT, Zarghami A, Makowiecki K, Stevens N, Ezegbe C, Kyle K, Wang C, Ly L, De La Rue K, Hinder MR, Johnson L, Rodger J, Cooper S, Cullen CL, Barnett M, Young KM, Taylor BV. Low-intensity repetitive transcranial magnetic stimulation is safe and well tolerated by people living with MS - outcomes of the phase I randomised controlled trial (TAURUS). Mult Scler J Exp Transl Clin. 2024 May 15;10(2):20552173241252571. doi: 10.1177/20552173241252571.
Shaw SR, Horne KS, Piguet O, Ahmed RM, Whitton AE, Irish M. Profiles of motivational impairment and their relationship to functional decline in frontotemporal dementia. J Neurol. 2024 Aug;271(8):4963-4971. doi: 10.1007/s00415-024-12430-0. Epub 2024 May 17.
Klistorner S, Barnett MH, Parratt J, Yiannikas C, Klistorner A. Quantifying chronic lesion expansion in multiple sclerosis: Exploring imaging markers for longitudinal assessment. Mult Scler Relat Disord. 2024 Jul;87:105688. doi: 10.1016/j.msard.2024.105688. Epub 2024 May 16.
Parsons MW, Yogendrakumar V, Churilov L, Garcia-Esperon C, Campbell BCV, Russell ML, Sharma G, Chen C, Lin L, Chew BL, Ng FC, Deepak A, Choi PMC, Kleinig TJ, Cordato DJ, Wu TY, Fink JN, Ma H, Phan TG, Markus HS, Molina CA, Tsai CH, Lee JT, Jeng JS, Strbian D, Meretoja A, Arenillas JF, Buck BH, Devlin MJ, Brown H, Butcher KS, O'Brien B, Sabet A, Wijeratne T, Bivard A, Grimley RS, Agarwal S, Munshi SK, Donnan GA, Davis SM, Miteff F, Spratt NJ, Levi CR; TASTE investigators. Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial. Lancet Neurol. 2024 Aug;23(8):775-786. doi: 10.1016/S1474-4422(24)00206-0. Epub 2024 Jun 13.
Xu Y, Aung HL, Hesam-Shariati N, Keay L, Sun X, Phu J, Honson V, Tully PJ, Booth A, Lewis E, Anderson CS, Anstey KJ, Peters R. Contrast Sensitivity, Visual Field, Color Vision, Motion Perception, and Cognitive Impairment: A Systematic Review. J Am Med Dir Assoc. 2024 Aug;25(8):105098. doi: 10.1016/j.jamda.2024.105098. Epub 2024 Jun 19.
Reid GA, Halmagyi GM, Whyte C, McCluskey PJ. Ocular vs neurosyphilis. are they the same? A guide to investigation and management. Eye (Lond). 2024 Aug;38(12):2337-2349. doi: 10.1038/s41433-024-03150-w. Epub 2024 Jun 24. 
Alysha D, Blair C, Thomas P, Pham T, Nguyen T, Cordato TR, Badge H, Chappelow N, Lin L, Edwards L, Thomas J, Hodgkinson S, Cappelen-Smith C, McDougall A, Cordato DJ, Parsons M. Comparative Prevalence of Cerebrovascular Disease in Vietnamese Communities in South-Western Sydney. J Cardiovasc Dev Dis. 2024 May 24;11(6):164. doi: 10.3390/jcdd11060164. 
Churchill L, Chen YC, Lewis SJG, Matar E. Understanding REM Sleep Behavior Disorder through Functional MRI: A Systematic Review. Mov Disord. 2024 Oct;39(10):1679-1696. doi: 10.1002/mds.29898. Epub 2024 Jun 27. 
Hu YB, Lu J, Li HX, Anderson CS, Liu ZM, Zhang B, Hao JJ. Spatiotemporal alterations in the brain oscillations of Arctic explorers. Brain Res Bull. 2024 Sep;215:111027. doi: 10.1016/j.brainresbull.2024.111027. Epub 2024 Jul 4. 
Nuñez M, Allende MI, González F, Cavada G, Anderson CS, Muñoz Venturelli P. Sex Differences in Profile and In-Hospital Death for Acute Stroke in Chile: Data From a Nationwide Hospital Registry. J Am Heart Assoc. 2024 Aug 6;13(15):e035152. doi: 10.1161/JAHA.123.035152. Epub 2024 Jul 18.
Li Q, Anderson CS, Salman RA, Hankey GJ, Billot L, Zhao Y, Tang G, Guo J, Song L; CHAIN Investigators. Statistical analysis plan for the Chinese Herbal medicine in Acute INtracerebral haemorrhage (CHAIN) trial. Cerebrovasc Dis. 2024 Jul 23. doi: 10.1159/000540444. Epub ahead of print. 
Reynolds M, Tan I, Nguyen K, Merheb V, Lee FXZ, Trewin BP, Lerch M, Shah S, Wolfe N, Buzzard K, Lechner-Scott J, Fabis-Pedrini M, Fok A, John N, Kneebone C, Yiannikas C, Brown DA, Kermode AG, Reddel S, Dale RC, Brilot F, Ramanathan S; Australasian MOGAD Study Group. The clinical relevance of MOG antibody testing in cerebrospinal fluid. Ann Clin Transl Neurol. 2024 Sep;11(9):2514-2519. doi: 10.1002/acn3.52163. Epub 2024 Jul 28.
Roos I, Sharmin S, Malpas C, Ozakbas S, Lechner-Scott J, Hodgkinson S, Alroughani R, Eichau Madueño S, Boz C, van der Walt A, Butzkueven H, Buzzard K, Skibina O, Foschi M, Grand'Maison F, John N, Grammond P, Terzi M, Prévost J, Barnett M, Laureys G, Van Hijfte L, Luis Sanchez-Menoyo J, Blanco Y, Oh J, McCombe P, Ramo Tello C, Soysal A, Prat A, Duquette P, Yamout BI, Khoury S, van Pesch V, Macdonell R, José Sá M, Slee M, Kuhle J, Maimone D, Spitaleri D, Willekens B, Asmi AA, Tallantyre E, Robertson NP, Coles A, L Brown JW, Kalincik T. Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis. Mult Scler. 2024 Aug;30(9):1163-1175. doi: 10.1177/13524585241267211. Epub 2024 Aug 1.
Matar E, Tinazzi M, Edwards MJ, Bhatia KP. Functional Movement Disorder as a Prodromal Symptom of Parkinson's Disease-Clinical and Pathophysiological Insights. Mov Disord. 2024 Nov;39(11):1952-1959. doi: 10.1002/mds.29958. Epub 2024 Aug 9. 
Anderson J, Yee BJ, Grunstein R, Matar E, Chadwick M, Machan E, Chapman J, Tai J, Saini B, Sivam S. Insights from a 10-year Australasian idiopathic hypersomnia patient data registry study. J Clin Sleep Med. 2024 Dec 1;20(12):1955-1964. doi: 10.5664/jcsm.11298.
Foxe D, Ainkaran G, Carrick J, Cheung SC, Ahmed RM, Narasimhan M, Burrell JR, Hwang YT, Irish M, Piguet O. Everyday Memory Disturbance in Primary Progressive Aphasia. Eur Neurol. 2024;87(4):177-187. doi: 10.1159/000540340. Epub 2024 Aug 16. 
Carcel C, Clancy L, Harris K, Peters R, Byrne A, Bassett K, Freed R, Hoyos CM, Rodgers A, Lindley R, Chalmers J, Xu Y, Woodward M, Ouyang M, Naismith SL, Anderson C. Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adults. BMJ Open. 2024 Aug 24;14(8):e080862. doi: 10.1136/bmjopen-2023-080862.
Jiang C, Wang Z, Du X, Wang Y, Gao M, Jia Z, Chai Z, Yang Z, Wang C, He L, Hu R, Lv Q, Wu J, Li X, Jia C, Han R, Arima H, Wang X, Neal B, Rodgers A, Hillis GS, Patel A, Li Q, Dong J, Anderson CS, Ma C. Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: Rationale and design of the CRAFT trial. Am Heart J. 2024 Dec;278:33-40. doi: 10.1016/j.ahj.2024.08.008. Epub 2024 Sep 7.
Klistorner S, Barnett MH, Parratt J, Yiannikas C, Klistorner A. Examining the relative contribution of slow-burning inflammation and chronic demyelination to axonal damage in chronic multiple sclerosis lesions. Mult Scler Relat Disord. 2024 Oct;90:105828. doi: 10.1016/j.msard.2024.105828. Epub 2024 Aug 22.
Kreiter D, Kalincik T, Hupperts R, Patti F, Spitaleri D, Foschi M, Surcinelli A, Maimone D, Yamout B, Khoury SJ, Lechner-Scott J, Ozakbas S, Gerlach O; MSBase Study Group. Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study. CNS Drugs. 2024 Nov;38(11):921-930. doi: 10.1007/s40263-024-01115-x. Epub 2024 Sep 6.
Stevens N, Ezegbe C, Fuh-Ngwa V, Makowiecki K, Zarghami A, Nguyen PT, Sansom J, Smith K, Laslett LL, Denham M, Cullen CL, Barnett MH, Hinder MR, Breslin M, Young KM, Taylor BV. A phase II trial examining the safety and preliminary efficacy of repetitive transcranial magnetic stimulation (rTMS) for people living with multiple sclerosis. Trials. 2024 Sep 8;25(1):598. doi: 10.1186/s13063-024-08425-x. 
Zhao Y, Cui W, Xie T, Zhao K, Li Y, Wan Y, Wang X, Li Q, Xiaoying C, Liu Z, Zhao H, Gong B, Wang R, Wu M, Wang D, Zheng Y, Chen Y, Chen Y, Guo Q, Gan C, Che F, Song L, Anderson CS, Guo J; for CHAIN investigators. Efficacy and Safety of Chinese Herbal Medicine in Patients with Acute Intracerebral Hemorrhage: Protocol for a Randomized Placebo-Controlled Double-Blinded Multicenter Trial. Cerebrovasc Dis. 2024;53(4):501-508. doi: 10.1159/000534761. Epub 2023 Oct 26.
You S, Wang Y, Wang X, Maeda T, Ouyang M, Han Q, Li Q, Song L, Zhao Y, Chen C, Delcourt C, Ren X, Carcel C, Zhou Z, Cao Y, Liu CF, Zheng D, Arima H, Robinson TG, Chen X, Lindley RI, Chalmers J, Anderson CS. Twenty-Four-Hour Post-Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study. J Am Heart Assoc. 2024 Sep 17;13(18):e036109. doi: 10.1161/JAHA.124.036109. Epub 2024 Sep 11.
Rautalin I, Krishnamurthi RV, Anderson CS, Barber PA, Barker-Collo S, Bennett D, Boet R, Correia JA, Douwes J, Law A, Nair B, Thrift AG, Ao BT, Tunnage B, Ranta A, Feigin V. Demographic disparities in the incidence and case fatality of subarachnoid haemorrhage: an 18-year nationwide study from New Zealand. Lancet Reg Health West Pac. 2024 Sep 17;52:101199. doi: 10.1016/j.lanwpc.2024.101199.
Appleton JP, Dixon M, Woodhouse LJ, Anderson CS, Ankolekar S, Cala L, England TJ, Godolphin PJ, Krishnan K, Mair G, Muir KW, Potter J, Price CI, Randall M, Robinson TG, Roffe C, Rothwell PM, Sandset EC, Saver JL, Siriwardena AN, Wardlaw JM, Sprigg N, Bath PM; RIGHT‐2 Investigators. Pre-hospital transdermal glyceryl trinitrate for transient ischaemic attack: Data from the RIGHT-2 trial. Eur J Neurol. 2024 Dec;31(12):e16502. doi: 10.1111/ene.16502. Epub 2024 Oct 11.
Timmins HC, Mok VCT, Kim SH, Shahrizaila N, Sung JY, Sobue G, Agustini S, Ward S, Anstey KJ, Talbot DL, Mazumder S, Tu S, Tan RH, Shin-Yi Lin C, O'Callaghan C, Michaelian JC, Jeon YH, Foxe D, Naismith SL, Piguet O, Ahmed R, Devenney E, Park SB, Kiernan MC. Regional health priorities for dementia: a roadmap for the Western Pacific. Lancet Reg Health West Pac. 2024 Sep 16;50:101179. doi: 10.1016/j.lanwpc.2024.101179.
Clarke AJ, Brodtmann A, Irish M, Mowszowski L, Radford K, Naismith SL, Mok VCT, Kiernan MC, Halliday GM, Ahmed RM. Risk factors for the neurodegenerative dementias in the Western Pacific region. Lancet Reg Health West Pac. 2024 Sep 16;50:101051. doi: 10.1016/j.lanwpc.2024.101051.
Calic Z, Peric S, Vujnic M, Bjelica B, Bozovic I, Rakocevic-Stojanovic V, Bradshaw A, Colebatch JG, Welgampola MS. Video head impulse gain is impaired in myotonic dystrophy types 1 and 2. Eur J Neurol. 2024 Dec;31(12):e16513. doi: 10.1111/ene.16513. Epub 2024 Oct 15.
Griffiths J, Adshead F, Al-Shahi Salman R, Anderson C, Bedson E, Bliss J, Boshoff A, Chen X, Cranley D, Doran P, Dunne F, Gamble C, Gillies K, Hood K, Kavanagh C, Malone J, McGregor N, McNamara C, Midha E, Moore K, Murphy L, Newman C, O'Reilly S, Perkins AM, Pett S, Sydes MR, Whitty L, You F, Fox L, Williamson PR. What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trials. BMJ Open. 2024 Oct 16;14(10):e088600. doi: 10.1136/bmjopen-2024-088600. 
Ouyang M, Ma L, Chen X, Wang X, Billot L, Li Q, Malavera A, Li X, Muñoz-Venturelli P, Silva A, Nguyen TH, Wahab KW, Pandian JD, Wasay M, Pontes-Neto OM, Abanto C, Arauz A, You C, Hu X, Song L, Anderson CS; INTERACT3 Investigators. Predictive Accuracy of Clinicians Estimates of Death and Recovery after Acute Intracerebral Hemorrhage: Pre-Specified Analysis in INTERACT3 Study. Cerebrovasc Dis. 2024 Oct 21:1-8. doi: 10.1159/000541985. Epub ahead of print. 
Crawford AM, Lorenzi EC, Saville BR, Lewis RJ, Anderson CS. Adaptive Clinical Trials in Stroke. Stroke. 2024 Nov;55(11):2731-2741. doi: 10.1161/STROKEAHA.124.046125. Epub 2024 Oct 22. 
Nguyen AL, Sormani MP, Horakova D, Havrdova EH, Barnett MH, De Stefano N, Battaglini M, Vaneckova M, Lui E, Gaillard F, Desmond PM, Prime H, Datta M, Van der Walt A, Jokubaitis VG, Podevyn F, Zivadinov R, Weinstock-Guttman B, D'hooghe MB, Nagels G, Van Pesch V, Laureys G, Van Hijfte L, Lechner-Scott J, Patti F, Cristiano E, Rojas JI, Sima DM, Van Hecke W, Kalincik T, Butzkueven H. Utility of icobrain for brain volumetry in multiple sclerosis clinical practice. Mult Scler Relat Disord. 2024 Dec;92:106148. doi: 10.1016/j.msard.2024.106148. Epub 2024 Nov 8. 
Wang Y, Maeda T, You S, Chen C, Liu L, Zhou Z, Robinson TG, Lindley RI, Delcourt C, Mair G, Wardlaw JM, Chalmers JP, Arima H, Huang Y, Kim JS, Lavados PM, Lee TH, Levi C, Parsons MW, Martins SC, Pandian JD, Pontes-Neto OM, Sharma VK, Nguyen TH, Wang J, Wu S, Liu M, Anderson CS, Chen X; ENCHANTED Investigators. Patterns and Clinical Implications of Hemorrhagic Transformation After Thrombolysis in Acute Ischemic Stroke: Results From the ENCHANTED Study. Neurology. 2024 Dec 10;103(11):e210020. doi: 10.1212/WNL.0000000000210020. Epub 2024 Nov 14. 
Murray NWG, Choma ME, Lo A, Thayer Z, Graham PL, Harvey EE. Assessing spatial memory using the Brown Location Test: Lateralizing seizures in a presurgical cohort of patients with temporal lobe epilepsy. Epilepsy Behav. 2024 Dec;161:110137. doi: 10.1016/j.yebeh.2024.110137. Epub 2024 Nov 14. Erratum in: Epilepsy Behav. 2025 Sep;170:110508. doi: 10.1016/j.yebeh.2025.110508. 
Zhang Y, Liu R, Zhao Y, Wang Z, Wang C, Li Q, Han D, Anderson CS, Du X, Dong J. Influenza vaccination in patients with acute heart failure (PANDA II): study protocol for a hospital-based, parallel-group, cluster randomized controlled trial in China. Trials. 2024 Nov 25;25(1):792. doi: 10.1186/s13063-024-08452-8. Erratum in: Trials. 2024 Dec 11;25(1):814. doi: 10.1186/s13063-024-08686-6.
Dyball AC, Wu XP, Kwok BYC, Wang C, Nham B, Pogson JM, Kong JHK, Taylor RL, Weber KP, Welgampola MS, Rosengren SM. After the n10: late oVEMP peaks in patients with unilateral vestibular loss and healthy volunteers. Exp Brain Res. 2024 Dec 2;243(1):10. doi: 10.1007/s00221-024-06947-z.
Rosengren SM, Nham B, Lim J, Parlane R, Dyball AC, Reid N, Halmagyi GM, Welgampola MS. Spatial numerical bias in acute vestibular neuritis. J Neurol. 2024 Dec 16;272(1):66. doi: 10.1007/s00415-024-12844-w.
Ouyang M, Anjum A, Mc Cawley FG, Wasay M, Ma L, Hu X, Chen X, Malavera A, Li X, Venturelli PM, Silva HA, Thang NH, Wahab KW, Pandian JD, Pontes-Neto OM, Abanto C, Cano-Nigenda V, Arauz A, You C, Jan S, Song L, Anderson CS, Liu H; INTERACT3 Investigators. Implementation of a goal-directed Care Bundle for intracerebral hemorrhage: Results of embedded process evaluation in the INTERACT3 trial. PLOS Glob Public Health. 2024 Dec 19;4(12):e0003711. doi: 10.1371/journal.pgph.0003711.
Ren X, Chen C, Wang X, Li Q, Zhao Y, You S, Ouyang M, Robinson T, Lindley RI, Arima H, Chen X, Chalmers J, Anderson CS, Song L. Influence of renal function on blood pressure control and outcome in thrombolyzed patients after acute ischemic stroke: post-hoc analysis of the ENCHANTED trial. Front Endocrinol (Lausanne). 2024 Dec 9;15:1341902. doi: 10.3389/fendo.2024.1341902.
Aguilar I, Bersani--Veroni T, Herbozo Contreras LF, Nikpour A, Querlioz D, Kavehei O. Metaplastic-EEG: Continuous Training on Brain-Signals. medRxiv. 2024:2024.05. 29.24308178.
Chatterton S, Clarke A, Satgunaseelan L, Soh HC, Ng K, Parratt K, Parratt J. Not all NMDA antibodies are equal: two cases of glioblastoma multiforme presenting with subacute neurological syndromes and positive NMDA antibodies. BMJ Neurol Open. 2024;4(Suppl 1):A48.1. https://neurologyopen.bmj.com/content/4/Suppl_1/A48.1
Guilfoyle D, Parratt K. Case report: snap, crackle, and pop! Unusual symptoms of motor dysfunction of the trigeminal nerve preceding trigeminal neuralgia. BMJ Neurol Open. 2024;5(Suppl 1):A14.3.
Halliday A, Vogrin S, Whitham E, Seneviratne U, Gillinder L, Jones D, et al. Real-world brivaracetam efficacy in adult epilepsy: an Australian multi-centre retrospective observational cohort study. BMJ Neurol Open. 2024;4(Suppl 1):A7.2. https://neurologyopen.bmj.com/content/4/Suppl_1/A7.2
Herbozo Contreras LF, Cui J, Yu L, Huang Z, Nikpour A, Kavehei O. KAN-EEG: Towards Replacing Backbone-MLP for an Effective Seizure Detection System. medRxiv. 2024:2024.06. 05.24308471.
Herbozo Contreras LF, Huang Z, Yu L, Nikpour A, Kavehei O. Biologically plausible algorithm for seizure detection: Toward AI-enabled electroceuticals at the edge. APL Mach Learn. 2024;2(2):026114. doi: 10.1063/5.0192875
Herbozo Contreras LF, Truong ND, Eshraghian JK, Xu Z, Huang Z, Bersani-Veroni TV, et al. Neuromorphic neuromodulation: Towards the next generation of closed-loop neurostimulation. PNAS Nexus. 2024;3(11):pgae488. doi: 10.1093/pnasnexus/pgae488
Herbozo Contreras LF, Yu L, Huang Z, Zhang Z, Nikpour A, Kavehei O. Tiny dLIF: A Dendritic Spiking Neural Network Enabling a Time-Domain Energy-Efficient Seizure Detection System. medRxiv. 2024:2024.05. 23.24307841.
Huang Z, Leung WH, Cui J, Yu L, Herbozo Contreras LF, Truong ND, et al. Cardiac abnormality detection with a tiny diagonal state space model based on sequential liquid neural processing unit. APL Mach Learn. 2024;2(2):026112. doi: 10.1063/5.0191574
Huang Z, Leung WH, Yu L, Herbozo Contreras LF, Zhang Z, Truong ND, et al. On-device edge-learning for cardiac abnormality detection using a bio-inspired and spiking shallow network. APL Mach Learn. 2024;2(2):026109. doi: 10.1063/5.0191571